Clinical trials
2 active studies led by Motif Neurotech, Inc., of 2 in all
Source: ClinicalTrials.gov, Studies with Motif Neurotech, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 2Markets in public records
- 0Regions & countries
- 2Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Motif Neurotech, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Motif Neurotech, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Markets where public records show them
Markets we cover where free public records show Motif Neurotech, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Healthcare Topics
The topics of the markets Motif Neurotech, Inc. is in.
From our blog
Stories on the topics Motif Neurotech, Inc. works in.
Adaptogens: Ancient Herbs, Modern Market
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Stress and Mood Supplements: Ashwagandha and Beyond
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
Antidepressants: Demand, Access and New Approaches
About 322 million people live with depression. Treatment works, but most people still do not get it.
Read